Results 91 to 100 of about 38,523,323 (145)
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy
, 2008 OBJECTIVE: To assess the long-term effect of HAART on non-Hodgkin lymphoma (NHL) incidence in people with HIV (PHIV). DESIGN: Follow-up of the Swiss HIV Cohort Study (SHCS). METHODS: Between 1984 and 2006, 12 959 PHIV contributed a total of 75 222 person-Rickenbach, Martin, Battegay, Manuel, Swiss, HIV Cohort Study, Franceschi, S., Rickenbach, M, Furrer, H, Polesel, J., Schmid, P, Levi, F., Probst-Hensch, Nicole M., Bouchardy, C., Clifford, G. M., Franceschi, Silvia, Dal Maso, Luigino, Hasse, B, Battegay, M., Probst-Hensch, Nicole M, Bouchardy, Christine, Swiss HIV Cohort Study, Rickenbach, M., Probst-Hensch, N M, Schmid, Patrick, Levi, F, Clifford, G M, Polesel, J, Furrer, Hansjakob, Hasse, Barbara, Schmid, P., Bouchardy, C, Franceschi, S, Furrer, H., Probst-Hensch Nicole, M., Clifford, Gary M., Dal Maso, L., Dal Maso, L, Hasse, B., Probst-Hensch, N. M., Levi, Fabio, Clifford Gary, M., Clifford, Gary M, Battegay, M, Bouchardy Magnin, Christine, Polesel, Jerry +42 morecore +1 more sourceThe comparative effectiveness of NRTI-sparing dual regimens in emulated trials using observational data from the Swiss HIV Cohort Study [PDF]
, 2018 BACKGROUND
Nucleoside (or nucleotide) reverse transcriptase inhibitors (NRTIs) cause side effects in some patients, prompting the use of either partly or fully NRTI-sparing regimens.
METHODS
We used data from the Swiss HIV Cohort Study to estimate the Swiss HIV Cohort Study, Calmy, A., Hachfeld, Anna, Günthard, Huldrych F, Young, Jim, Tarr, Philip E, Young, J., Cavassini, M., Scherrer, A.U., Günthard, H.F., Scherrer, Alexandra U, Vernazza, P., Vernazza, Pietro, Hachfeld, A., Bucher, H.C., Tarr, P.E., Calmy, Alexandra, Bucher, Heiner C, Bernasconi, Enos, Cavassini, Matthias, Bernasconi, E., Vernazza P, Hachfeld A, Calmy A, Cavassini M, Tarr PE, Bucher HC, Günthard HF, Scherrer AU, Young J, Bernasconi E, Enos Bernasconi, Alexandra U Scherrer, Pietro Vernazza, Jim Young, Heiner C Bucher, Alexandra Calmy, Philip E Tarr, null null, Huldrych F Günthard, Matthias Cavassini, Anna Hachfeld +41 morecore +1 more sourceAssociation Between Smoking and Lipid Profile in Men Aged 35 to 70 Years: Dose–Response Analysis
American Journal of Men's HealthDyslipidemia is linked to various health complications, including cardiovascular disease and inflammation. This study aimed to assess the association between smoking and lipid profile in the Tabari cohort population.Mahmood Moosazadeh, Pedram Ebrahimnejad, Motahareh Kheradmand, Mona Modanloo, Fatemeh Mardanshah, Shamim Mahboobi, Mehrasa Rostamian, Aysa Safajoo, Marzieh Dehghanzadegan, Fatemeh kianmehr +9 moredoaj +1 more sourceCharacteristics of foreign-born persons in the swiss hepatitis C cohort study: implications for screening recommendations [PDF]
, 2016 BACKGROUND: Switzerland recommends individuals who originate from high-prevalence countries to be screened for hepatitis C virus (HCV) infection. However, not all these persons are equally at risk. We thus aimed to describe the number and characteristics Olivia Keiser, Negro, F., Fabio Giudici, Moriggia, A., Keiser, O., Barbara Bertisch (3167913), Janne Estill (378310), Estill, J., Moriggia, Alberto, Moradpour, Darius, Giudici, Fabio, Darius Moradpour (15815), Bertisch, B., Alberto Moriggia (3167910), Müllhaupt, Beat, Barbara Bertisch, Estill, Janne Anton Markus, Keiser, Olivia, Moradpour, D., Bertisch, Barbara, Negro, Francesco, Beat Müllhaupt, Janne Estill, Fabio Giudici (3167907), Swiss Hepatitis C Cohort Study, Francesco Negro, Francesco Negro (205592), Olivia Keiser (93991), Beat Müllhaupt (416436), Alberto Moriggia, Darius Moradpour, Giudici, F., Estill, Janne, Müllhaupt, B., Moriggia A, Moradpour D, Bertisch B, Estill J, Giudici F, Negro F, Müllhaupt B, Keiser O +41 morecore +2 more sourcesIncident Hepatitis C Virus Infections in the Swiss HIV Cohort Study: Changes in Treatment Uptake and Outcomes Between 1991 and 2013. [PDF]
, 2015 Background: The hepatitis C virus (HCV) epidemic is evolving rapidly in patients infected with human immunodeficiency virus (HIV). We aimed to describe changes in treatment uptake and outcomes of incident HCV infections before and after 2006, the time ...A. Calmy, R. Speck, D. Haerry, Janine Rohrbach, B. Martinez de Tejada, Martinez de Tejada, B., Hösli, I., E. Bernasconi, Wandeler, G., Marion Schlauri, Marcel Stöckle, Battegay, M., Vernazza, P., Rudin, C., Kahlert, C., Böni, J., Nadal, D., J. Schüpbach, Weber, R., Kouyos, R., Jaquier, M.E., Andri Rauch, Dollenmaier, G., Egger, M., Metzner, K.J., Schmid, P., M. Hoffmann, Günthard, H., Rohrbach, J., Telenti, A., C.A. Fux, Hasse, B., Yerly, S., P. Schmid, Fux, C.A., Salazar-Vizcaya, L., C. Burton-Jeangros, Burton-Jeangros, C., H. Furrer, Patrick Schmid, Calmy, A., Trkola, A., M. Egger, Enos Bernasconi, O. Keiser, Marie-Eve Jaquier, Hirsch, H.H., Cavassini, M., Aubert, V., Gorgievski, M., J. Fehr, D. Nicca, Fellay, J., Müller, N., L. Kaiser, A. Telenti, Tarr, P., Jan Fehr, Rickenbach, M., Metzner, K., V. Aubert, G. Dollenmaier, G. Pantaleo, Furrer, H., Karin J. Metzner, I. Hösli, B. Hasse, Klimkait, T., Fehr, J., H.H. Hirsch, M. Cavassini, Keiser, O., Stöckle, M., A. Trkola, L. Elzi, Haerry, D., C. Rudin, G. Martinetti, P. Vernazza, Kovari, H., Regenass, S., M. Gorgievski, Hansjakob Furrer, J. Fellay, M. Rickenbach, Martinetti, G., T. Klimkait, Ambrosioni, J., F. Schöni-Affolter, Nicca, D., S. Yerly, Bernasconi, E., Olivia Keiser, Kaiser, L., R. Weber, A. Rauch, Elzi, L., P. Tarr, C. Kahlert, Rauch, A., Ledergerber, B., J. Böni, Pantaleo, G., M. Battegay, Juan Ambrosioni, D. Nadal, Gilles Wandeler, Luisa Salazar-Vizcaya, R. Kouyos, S. Regenass, Schüpbach, J., K. Metzner, H. Kovari, Hoffmann, M., H. Günthard, Speck, R., N. Müller, B. Ledergerber, Bucher, H.C., Schlauri, M., Matthias Cavassini, H.C. Bucher, Schöni-Affolter, F., Nicca D, Swiss HIV Cohort Study, Metzner, Karin J, Bernasconi E, Regenass S, Schlauri M, Böni J, Salazar-Vizcaya, Luisa, Furrer H, Ambrosioni J, Haerry D, Fehr, Jan, Aubert V, Fux CA, Cavassini, Matthias, Klimkait T, Schüpbach J, Stöckle, Marcel, Wandeler, Gilles, Battegay M, Trkola A, Calmy A, Yerly S, Tarr P, Metzner K, Ledergerber B, Furrer, Hansjakob, Burton-Jeangros C, Keiser O, Rickenbach M, Pantaleo G, Wandeler G, Stöckle M, Kahlert C, Rauch, Andri, Martinetti G, Rohrbach, Janine, Rudin C, et al, Weber R, Ambrosioni, Juan, Dollenmaier G, Rohrbach J, Elzi L, Vernazza P, Schöni-Affolter F, Gorgievski M, Fehr J, Jaquier ME, Schmid P, Telenti A, Hoffmann M, Egger M, Fellay J, Nadal D, Kaiser L, Bernasconi, Enos, Kouyos R, Hösli I, Martinez de Tejada B, Jaquier, Marie-Eve, Metzner KJ, Schmid, Patrick, Speck R, Rauch A, Salazar-Vizcaya L, Hirsch HH, Hasse B, Schlauri, Marion, Cavassini M, Keiser, Olivia, Müller N, Bucher HC, Günthard H, Kovari H +197 morecore +2 more sourcesPrevalence and risk factors for venous thromboembolic complications in the Swiss Inflammatory Bowel Disease Cohort.
, 2016 OBJECTIVE
Inflammatory bowel disease (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), is associated with the occurrence of venous thromboembolism (VTE) such as deep vein thrombosis (DVT) and pulmonary embolism (PE).Safroneeva, Ekaterina, Engelberger, R.P., Safroneeva, E., Biedermann, L., Alatri, Adriano, Vavricka, Stephan, Mazzolai, Lucia, Calanca, L., Fournier, N., Vavricka, S., Calanca, Luca, Engelberger, Rolf Peter, Fournier, Nicolas, Schoepfer, A., Mazzolai, L., Alatri, A., Schoepfer, Alain, Swiss IBD Cohort Study Group, Biedermann, Luc, Fournier N, Biedermann L, Engelberger RP, Vavricka S, Safroneeva E, Schoepfer A, Mazzolai L, Calanca L, Alatri A +27 morecore +1 more sourceAntibodies against HPV16E6 oncoprotein in the Swiss HIV Cohort Study: kinetics and anal cancer risk prediction. [PDF]
, 2019 Our aim was to describe HPV16E6 antibody kinetics prior to anal cancer in people living with HIV/AIDS (PLWHA) and evaluate the possible contribution of HPV16E6 serology to anal cancer risk prediction.Battegay, Manuel, Günthard, Huldrych F, Enos Bernasconi, Alexandra U. Scherrer, Brenner, Nicole, Pablo Valladares, Hirsch, Hans H, Waterboer, Tim, Darling, Katharine E A, Jean‐Damien Combes, Gary M. Clifford, Tim Waterboer, Valladares, Pablo, Waldeck, Frederike, Bernasconi, Enos, Swiss HIV Cohort Study, Barbara Bertisch, Huldrych F. Günthard, Hans H. Hirsch, Combes, Jean-Damien, Bertisch, Barbara, Frederike Waldeck, Katharine E.A. Darling, Christoph Hauser, Manuel Battegay, Hauser, Christoph, Scherrer, Alexandra U, Clifford, Gary M; https://orcid.org/, Nicole Brenner, Clifford, Gary M, Hauser, C., Combes, J.D., Battegay M, Valladares P, Battegay, M., Darling KEA, Waldeck, F., Bertisch B, Brenner N, Clifford, G.M., Hirsch HH, Scherrer AU, Hauser C, Bernasconi E, Bernasconi, E., Waldeck F, Hirsch, H.H., Bertisch, B., Waterboer T, Waterboer, T., Darling, KEA, Valladares, P., Günthard, H.F., Scherrer, A.U., Günthard HF, Combes JD, Brenner, N., Clifford GM +57 morecore +2 more sourcesNeutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in COVID-19 Patients and Control Group and Relationship with Disease Prognosis
Caspian Journal of Internal Medicine, 2020 Background: The present study aimed to compare the complete blood count (CBC) indices between COVID-19 patients and the control group, and assess the relationship of these indices with COVID-19 prognosis given the role of complete blood counts in the ...Mohammad Eslamijouybari, Keyvan Heydari, Iradj Maleki, Mahmood Moosazadeh, Akbar Hedayatizadeh-Omran, Lale Vahedi, Roya Ghasemian, Ali Sharifpour, Reza Alizadeh-Navaei +8 moredoaj